• Login
Read without ads. Subscribe KOMPAS.com+

Measuring Indonesia's Medical Sovereignty at the ASEAN Summit

17 November 2026, 05:35 WIB
Dr. Ray Wagiu Basrowi,
Ferril Dennys

Tim Redaksi

This article was translated by AI. Read the original article on Kompas.com. See Original

ASEAN Summit 49 in Manila, themed "Navigating Our Future, Together," presents a unique opportunity for Indonesia to assess and gauge its medical sovereignty regionally.

Why should we measure medical aspects in such a significant forum? Because our country is the largest contributor to medical consultations, treatments, and even medical tourism within ASEAN, primarily benefiting Singapore, Malaysia, and recently starting to include Thailand.

But what exactly are we measuring? How does this relate to sovereignty? The answer is that it certainly connects and will define Indonesia's future sovereignty.

However, measuring medical sovereignty must begin with a clear attitude towards patient choices, as countries need to respect those decisions and understand why domestic services have not become a preferred option.

We must also be realistic that some individuals will continue to seek treatment abroad, even as Indonesia’s services improve.

What needs to be measured is Indonesia's ability to convert the significant flow of patients into a bargaining position that advocates for safer services and more beneficial cooperation.

This is where medical issues become a diplomatic measure, as patients can select hospitals but cannot negotiate cross-border promotional oversight, data exchange, or complaint mechanisms between two countries.

There are interests that can only be advanced through intergovernmental relations, and a summit level like ASEAN should provide political direction for these initiatives.

The motivations from the patients' side are quite understandable as they seek expertise, certainty, comfort, or service experience perceived as superior, so Indonesia must examine its own systemic shortcomings that contribute to this outbound trend.

However, discussions become lopsided if the entire responsibility is placed on the home country while the destination country adeptly develops new methods to attract patients.

When neighboring governments support medical tourism growth as an industry, that support should come with a willingness to strengthen protections for those utilizing their services.

The enormity of this interest is evident in a report by the Malaysia Healthcare Travel Council, which noted 968,000 health tourism arrivals from Indonesia in 2025, generating revenues of RM 2.2 billion.

This count does not necessarily equate to unique individuals, and the numbers originate from destination countries' industry development agencies.

Such data substantiates that the relationship holds significant economic implications, hence it is reasonable for Indonesia to spark discussions that transcend mere promotion and medical transactions.

The destination country certainly has the right to showcase its service advantages, just as patients have the right to choose.



Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.
Read without ads. Subscribe KOMPAS.com+
Read without ads. Subscribe KOMPAS.com+
Read without ads. Subscribe KOMPAS.com+
Close Ads

Copyright 2008 - 2026 PT. Kompas Cyber Media (Kompas Gramedia Digital Group). All Rights Reserved.

View